US2007172849A1PendingUtilityA1

Detection of markers in nascent proteins

Assignee: UNIV BOSTONPriority: May 11, 1994Filed: Oct 30, 2006Published: Jul 26, 2007
Est. expiryMay 11, 2014(expired)· nominal 20-yr term from priority
G01N 33/532C07C 205/45C07D 311/16C07D 495/04A61K 41/0042G01N 33/582A61K 38/00C12Q 1/68C07K 1/1077C07H 19/04C07D 405/12C12P 21/00C07K 1/13C07H 21/00C07D 207/404C07C 205/57
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention is directed to methods for the non-radioactive labeling, detection, quantitation and isolation of nascent proteins translated in a cellular or cell-free translation system. tRNA molecules are misaminoacylated with non-radioactive markers which may be non-native amino acids, amino acid analogs or derivatives, or substances recognized by the protein synthesizing machinery. Markers may comprise cleavable moieties, detectable labels, reporter properties wherein markers incorporated into protein can be distinguished from unincorporated markers, or coupling agents which facilitate the detection and isolation of nascent,protein from other components of the translation system. The invention also comprises proteins prepared using misaminoacylated tRNAs which can be utilized in pharmaceutical compositions for the treatment of diseases and disorders in humans and other mammals, and kits which may be used for the detection of diseases and disorders.

Claims

exact text as granted — not AI-modified
1 . A conjugate, comprising a substrate covalently coupled to a detectable moiety through a cleavable linker, said substrate selected from the group consisting of nucleosides and nucleotides, said detectable moiety having the property of fluorescence.  
     
     
         2 . The conjugate of  claim 1 , wherein said substrate is a nucleotide selected from the group consisting of NTP, dNTP and ddNTP.  
     
     
         3 . The conjugate of  claim 2 , wherein said nucleotide is part of an oligonucleotide.  
     
     
         4 . The conjugate of  claim 1 , wherein said detectable moiety comprises coumarin.  
     
     
         5 . The conjugate of  claim 1 , wherein said detectable moiety is selected from the group consisting of rhodamines and fluoresceins.  
     
     
         6 . A method, comprising: 
 a) providing i) nucleic acid, ii) the conjugate of  claim 1 , and iii) a polymerase; and    b) mixing said nucleic acid and said polymerase in the presence of said conjugate under conditions such that said conjugate is incorporated into said nucleic acid to produce labeled nucleic acid.    
     
     
         7 . The method of  claim 6 , wherein said nucleic acid is RNA.  
     
     
         8 . The method of  claim 6 , wherein said nucleic acid is DNA.

Join the waitlist — get patent alerts

Track US2007172849A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.